Fiduciary Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,433
Closed -$209K 84
2026
Q1
$209K Sell
7,433
-1,065
-13% -$28.4K 0.06% 71
2025
Q4
$212K Buy
8,498
+30
+0.4% +$757 0.06% 74
2025
Q3
$216K Buy
+8,468
New +$209K 0.07% 77
2023
Q4
Sell
-6,617
Closed -$219K 65
2023
Q3
$219K Buy
6,617
+600
+10% +$21.2K 0.1% 60
2023
Q2
$221K Sell
6,017
-42
-0.7% -$1.64K 0.1% 42
2023
Q1
$247K Sell
6,059
-34
-0.6% -$1.47K 0.12% 41
2022
Q4
$312K Buy
6,093
+3
+0% +$144 0.15% 37
2022
Q3
$266K Sell
6,090
-271
-4% -$13.2K 0.14% 32
2022
Q2
$334K Sell
6,361
-52
-0.8% -$2.65K 0.17% 34
2022
Q1
$332K Sell
6,413
-4,618
-42% -$240K 0.18% 35
2021
Q4
$651K Sell
11,031
-1,950
-15% -$96.6K 0.37% 31
2021
Q3
$558K Sell
12,981
-25,837
-67% -$1.14M 0.3% 48
2021
Q2
$1.52M Sell
38,818
-15,626
-29% -$608K 1.31% 17
2021
Q1
$1.97M Buy
54,444
+48,021
+748% +$1.71M 2.98% 10
2020
Q4
$236K Sell
6,423
-1,777
-22% -$65.2K 0.33% 50
2020
Q3
$286K Buy
8,200
+142
+2% +$4.98K 0.47% 40
2020
Q2
$294K Sell
8,058
-2,533
-24% -$86.1K 0.65% 32
2020
Q1
$328K Sell
10,591
-2,082
-16% -$70.9K 0.62% 30
2019
Q4
$459K Buy
+12,673
New +$451K 0.42% 36

Other funds holding PFE

Fiduciary Planning's PFE Position: Q2 2026 in Review

Fiduciary Planning sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,433 shares — an estimated $209K sold.

Fiduciary Planning first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $1.97M in Q1 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fiduciary Planning reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Fiduciary Planning sold 7,433 Pfizer shares in Q2 2026, an estimated $209K.
  • Fiduciary Planning first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
  • Fiduciary Planning's Pfizer position peaked at $1.97M in Q1 2021.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fiduciary Planning's 13F filing for Q2 2026, filed 31 Jul 2026.